In vitro and in vivo Evaluation of Ibuprofen Nanosuspensions for Enhanced Oral Bioavailability
Authors:
Open Access
- 6 April 2021
- journal article
- research article
- Published by S. Karger AG in Medical Principles and Practice
- Vol. 30 (4) , 361-368
Abstract
Introduction: The objectives were to prepare, characterize, and evaluate different ibuprofen (IBU) nanosuspensions. Methods: The nanosuspensions produced by ultrahomogenization were compared with a marketed IBU suspension for particle size, in vitro dissolution, and in vivo absorption. Five groups of rabbits were orally administered with 25 mg/kg of IBU nanosuspension, nanoparticles, unhomogenized suspension, marketed product, and untreated suspension. A sixth group received 5 mg/kg IBU intravenously. Blood samples obtained were analyzed by chromatography. Results: The nanosuspensions showed significant decrease in particle size. Polyvinylpyrrolidone (PP) K30 profoundly increased aqueous solubility of IBU. Addition of Tween 80 (TW), in equal amount as PP (IBU:PP:TW, 1:2:2 w/w), resulted in much smaller particle size and better dissolution rate. The Cmax values achieved were 14.8 ± 1.64, 11.1 ± 1.37, 9.01 ± 0.761, 7.03 ± 1.38, and 3.23 ± 1.03 μg/mL, and the tmax values were 36 ± 8.2, 39 ± 8.2, 100 ± 17.3, 112 ± 15, and 105 ± 17 min for the nanosuspension, nanoparticle, unhomogenized suspension, marketed IBU suspension, and untreated IBU suspension in water, respectively. Bioavailability of the different formulations relative to the marketed suspension was found to be in the following sequence: nanosuspension > unhomogenized suspension > nanoparticles > untreated IBU suspension. Conclusion: IBU/PP/TW nanosuspension showed enhanced in vitro and in vivo performance as compared to the marketed product. Nanosuspensions prepared by the ultrahigh-pressure homogenization technique can be used as a good formulation strategy to enhance the rate and extent of absorption of poorly soluble drugs.Keywords
This publication has 28 references indexed in Scilit:
- Preparation, characterization and in vitro dissolution study of Nitrazepam: Cyclodextrin inclusion complexJournal of Pharmacy and Bioallied Sciences, 2012
- Oral formulation strategies to improve solubility of poorly water-soluble drugsExpert Opinion on Drug Delivery, 2011
- Formulation and pharmacokinetic evaluation of a paclitaxel nanosuspension for intravenous deliveryInternational Journal of Nanomedicine, 2011
- Effects of concentration of dispersions on particle sizing during production of fine particles in wet grinding processPowder Technology, 2011
- Physicochemical characterization of gliclazide–macrogol solid dispersion and tablets based on optimized dispersionDrug Development and Industrial Pharmacy, 2010
- Comparison of solid dispersions produced by supercritical antisolvent and spray-freezing technologiesInternational Journal of Pharmaceutics, 2009
- Coprecipitation of pharmaceutical actives and their structurally related additives by the RESS processPowder Technology, 2009
- Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution ratesAdvanced Drug Delivery Reviews, 2007
- Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugsJournal of Pharmacy and Pharmacology, 2004
- Improving drug solubility for oral delivery using solid dispersionsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2000